Mechanistic classification of immune checkpoint inhibitor toxicity as a pointer to minimal treatment strategies to further improve survival

McGonagle, D, Bragazzi, NL, Amital, H et al. (1 more author) (2020) Mechanistic classification of immune checkpoint inhibitor toxicity as a pointer to minimal treatment strategies to further improve survival. Autoimmunity Reviews, 19 (2). 102456. ISSN 1568-9972

Abstract

Metadata

Authors/Creators:
  • McGonagle, D
  • Bragazzi, NL
  • Amital, H
  • Watad, A
Copyright, Publisher and Additional Information: © 2019, Elsevier B.V. All rights reserved. This is an author produced version of an article published in Autoimmunity Reviews. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Immune checkpoint inhibitors; ICI; Immune related adverse events; irAEs
Dates:
  • Published: February 2020
  • Accepted: 25 July 2019
  • Published (online): 12 December 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Experimental Musculoskeletal Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 27 Jan 2020 11:17
Last Modified: 27 Jan 2020 11:17
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.autrev.2019.102456

Download

Accepted Version


Embargoed until: 12 December 2020

Filename: Immune Checkpoint Inhibitors and Cancer Outcomes 9.11.19.pdf

Licence: CC-BY-NC-ND 4.0

Share / Export

Statistics